Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

In the media

Poor return on investment in developing new antibiotics

2 July 2014: Prime Minister David Cameron has called for global action to tackle antibiotic resistance. Responding to this the Royal Pharmaceutical Society spoke to a number of news outlets including BBC News 24, BBC World, Channel 5 News and BBC Radio Scotland. RPS Chief Scientist Jayne Lawrence told BBC News 24: “I think it’s important not to scare people but if we don’t act now and do something about the need for new antibiotics and the way we use the antibiotics I think there is a possibility that we will certainly end up at a time when it is perhaps dangerous to take an operation, just a routine operation that we wouldn’t think about now… It’s increasingly hard to find new antibiotics in the pharmaceutical companies, coupled with the fact that the regulatory burden of getting these drugs through clinical trials onto the market is very high and the incentive for pharmaceutical industry to produce these new antibiotics is low. They don’t get much return on their investment.”

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20065799

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
PJJ Static MPU
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.